Debtwire

At our Miami event in December last year we launched next-generation Debtwire. The first end-to-end platform for Leveraged Capital Markets professionals. Since then, we've been working on improving our capabilities. Last week in Miami, our Chief Content Officer Yana Morris took us on a fascinating journey through the evolution of Debtwire's next generation, using the captivating story of Rite Aid as a guide. This name has been a constant source of focus for our team for the past two years, offering invaluable editorial and data insights through advanced capabilities of our revolutionary platform. Trial next-generation Debtwire today: https://lnkd.in/eRZa5Rzc

Thrive Pet Healthcare has hired Evercore as financial advisor as the veterinary practice management company is grappling with persistent cash deficits and challenges retaining vets, according to three sources familiar with the matter. The TSG Consumer Partners-backed company’s liquidity position deteriorated over the past year as business conditions worsened: https://lnkd.in/ejefAeUp

Welcome aboard, Francesca Ricciardi! Francesca joins Debtwire from TMT Finance, where she spent two years covering M&A deals in the technology sector across the EMEA region. Prior to that, she was a reporter at Alliance News, focusing on Milan-listed companies' M&A operations, macroeconomics, and politics. Francesca holds a bachelor’s degree in Journalism from City, University of London. Born and raised in Rome, she speaks Italian, English, Spanish, and a bit of French. Welcome to the team, Francesca!

What has caused Leveraged Finance (LevFin) markets to regain their appeal in 2024? Discover the key factors in our 1H24 LevFin Highlights report 👉 https://lnkd.in/ebR9tGyU LevFin issuance across the US and European institutional loan and high-yield (HY) bond markets in 1H24 more than tripled from a year ago, ballooning to USD 1trn. The rebound in issuance has been driven mainly by refinancing activity, while the undersupply of new-money paper amid strong investor demand has given rise to a deluge of loan repricing exercises on both sides of the Atlantic. As interest-rate hikes plateaued and fears of recession subsided, LevFin markets regained their appeal. A rosier macroeconomic outlook and the prospect of rate cuts propelled investors to funnel money back into HY funds, while collateralised loan obligation (CLO) issuance also surged this year.

"The opportunity in the UK is just enormous" Giovanni Amodeo sat down with Ross Morrow, co-founder and executive director of DunPort Capital Management, to dive into the intricacies of establishing a niche in European mid-market private lending. Their discussion not only shed light on DunPort’s business model and market philosophy but also highlighted the broader trends influencing the private lending landscape in Europe. Watch the full interview here: https://lnkd.in/e9zuZ5Ni #IONInfluencers

We're thrilled to welcome our new Covenant Analyst, Matthew Dunlap, to the Debtwire team! Matthew is a leveraged finance attorney with over 12 years of experience, having practiced in both the US and UK. He has represented corporate, private equity, and investment bank clients, and has a particular interest in environmental, social, and governance issues, including sustainable finance and corporate disclosure. Welcome aboard, Matthew!

🌍 Curious about the latest trends in the global loan market for the first half of this year? Explore Debtwire's 1H24 Loan Highlights report: https://lnkd.in/erQy67e9 The loan markets in the Americas, EMEA, and Asia-Pacific regions serve as a useful gauge of improvement compared to the previous year. Combined volumes across these regions amounted to USD 2.6trn in 1H24, marking a 13% rise from 2023 YTD. Volumes have been boosted mainly by the Americas, the biggest market in the world. The volume printed in 1H24 (USD 1.76trn) jumped 31% from 2023 YTD. Volume in 2Q24 alone (USD 898bn) was the highest quarterly figure in two years. Dive into our comprehensive review of loan market activity today!

📢 The Debtwire Forum Asia Pacific (https://lnkd.in/gTQ6UuyR) returns on 10 October at the Four Seasons Hotel in Hong Kong and online. Join us in this annual leveraged capital market event to network with 800+ senior credit professionals including institutional investors, buy-side hedge funds, #privatecredit funds, #restructuring specialists and professional advisors. Hear from our expert speakers to discover the latest trends and opportunities in Asian credit. 👉 Register now to save 30%: https://lnkd.in/gZPipbfT #DebtwireAPAC #Savethedate

Hertz, the rental car giant, has recently completed a $1.65bn bond issuance as it drives forward with new senior management focused on cost-cutting, revenue-optimizing, and capitalizing on the Hertz and Dollar Thrifty brands.   Hertz has made its fleet refresh and rotation a top priority, aiming to significantly reduce the proportion of high capital cost vehicles accumulated, due to challenges faced by original equipment manufacturers post-COVID. With more affordable vehicles now available in volume, Hertz is well-positioned to enhance its fleet moving forward. Stay informed with Debtwire as we track Hertz’s progress: https://lnkd.in/eeqNCxSV Not a subscriber? Start your free trial today: https://lnkd.in/eFK752A2 #Hertz #ElectricVehicles #Bonds

Last week the US Supreme Court rejected Purdue Pharma’s reorganization plan’s nonconsensual, non-debtor third-party releases granted to the company’s owners, the Sacker family, which would have protected them from further liability over the American opioid epidemic. The Court ruled that non-consensual third-party releases, such as the one shielding the Sacklers from further lawsuits in exchange for a $5.5 billion contribution to opioid claimants, are impermissible. The ruling disrupts Purdue Pharma’s key settlement plan for exiting bankruptcy and may delay compensation for opioid victims. This decision also has broader implications, challenging a common strategy used by businesses facing mass tort claims. Stay informed with Debtwire as we track this case: https://lnkd.in/eFQ27prg Not a subscriber? Start your free trial today: https://lnkd.in/eFK752A2 #PurduePharma #MassTorts #Bankruptcy